Aclaris Therapeutics Stock Performance
as on November 2, 2026 at 2:16 pm IST
Day's Low
Day's High
$3.87$4.07
2.52%
Downside
2.52%
Upside
52 Week's Low
52 Week's High
$2.10$6.6047.10%
Downside
66.24%
Upside
Aclaris Therapeutics share price movements today
- Previous Close
- $3.99
- Open
- $4.02
- Volume
- 1.5M
- Market Cap
- $615.3M
- Day's Low - High
- $3.87 - $4.07
- 52 Week Low - High
- $2.10 - $6.60
Aclaris Therapeutics Historical Returns
- 1 Month Return
- -9.57 %
- 3 Month Return
- -23.65 %
- 1 Year Return
- + 57.54 %
- 3 Year Return
- -21.7 %
- 5 Year Return
- -75.91 %
Aclaris Therapeutics Stock Fundamentals & Key Indicators
Check Aclaris Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$615.3M
EPS (TTM)
-0.58
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.84
Industry PE ratio
-7.33
PEG Ratio
-0.15
EBITDA
-75.3M
Revenue (TTM)
8.2M
Profit Margin
95.61%
Return On Equity TTM
-61.65%
Aclaris Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aclaris Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $615.3M | -75.91% | -6.84 | 95.61% | 0.00% | |
| Neutral | $88.5B | -36.40% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 208.09% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 45.26% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Aclaris Therapeutics Stock including INR - Dollar returns
The Aclaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Aclaris Therapeutics investment value today
Current value as on today
₹1,68,596
Returns
₹68,596
(+68.6%)
Returns from Aclaris Therapeutics Stock
₹57,540 (+57.54%)
Dollar Impact
₹11,056 (+11.06%)
Analyst Recommendation on Aclaris Therapeutics Stock
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Aclaris Therapeutics. Average target price of $10.36
Aclaris Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Aclaris Therapeutics.
What analysts predicted
61.68%UPSIDE
Target Price
$10.36
Current Price
$3.97
Analyzed by
3 Analysts
High
$16
Target
$10.36
Low
$12
Aclaris Therapeutics target price $10.36, a slight upside of 61.68% compared to current price of $3.97. According to 3 analysts rating.
Indian Investors' Interest in Aclaris Therapeutics Stock
Search interest for Aclaris Therapeutics Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:42% versus previous 30 day period
Aclaris Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Aclaris Therapeutics Annual Profit & Loss
All numbers in Millions USD
Aclaris Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Aclaris Therapeutics Annual Cash Flow
All numbers in Millions USD
Aclaris Therapeutics News & Key Events
Today's Timeline - 27 October
Tue, 04:01 PM
-Aclaris announces positive results for ATI-052 trials in atopic dermatitis and asthma, indicating strong clinical responses.
Tue, 04:20 PM
-Aclaris prices 7.79M shares at $3.50 in public offering, expected to generate approximately $50M.
Insights on Aclaris Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, ACRS stock has moved up by 57.5%
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 233.0%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 658.8%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 1.99M → 1.62M (in $), with an average decrease of 18.4% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -14.61M → -21.50M (in $), with an average decrease of 14.7% per quarter
About Aclaris Therapeutics
| Organisation | Aclaris Therapeutics |
| Headquarters | 640 Lee Road, Wayne, PA, 19087, US |
| Industry | Biotechnology |
| CEO | Neal S. Walker |
Key Management of Aclaris Therapeutics
Name | Title |
|---|---|
Mr. James Loerop | Chief Business Officer |
Mr. William C. Roberts | Senior Vice President of Corporate Communications & Investor Relations |
Mr. Matthew Rothman J.D. | General Counsel & Corporate Secretary |
Dr. Jesse W. Hall M.D. | Chief Medical Officer |
Ms. Nina Samra M.S. | Senior Vice President of Clinical Operations |
Dr. Neal S. Walker D.O., M.D. | Co-Founder, CEO & Chairman |
Dr. Hugh M. Davis Ph.D. | President, COO & Director |
Mr. Kevin Balthaser | Chief Financial Officer |
Dr. Roland Kolbeck Ph.D. | Chief Scientific Officer |
Mr. Steve Tucker | Executive Vice President of Project Leadership |
FAQs
What is Aclaris Therapeutics share price today?
Aclaris Therapeutics share price today is $3.97 as on at the close of the market. Aclaris Therapeutics share today touched a day high of $4.07 and a low of $3.87.
What is the 52 week high and 52 week low for Aclaris Therapeutics share?
Aclaris Therapeutics share touched a 52 week high of $6.60 on and a 52 week low of $2.10 on . Aclaris Therapeutics stock price today i.e. is closed at $3.97,which is 39.85% down from its 52 week high and 89.05% up from its 52 week low.
What is Aclaris Therapeutics's market capitalisation today?
Aclaris Therapeutics market capitalisation is $0.00T as on .
How to invest in Aclaris Therapeutics Stock (ACRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aclaris Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Aclaris Therapeutics Stock (ACRS) from India?
Indian investors can start investing in Aclaris Therapeutics (ACRS) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Aclaris Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aclaris Therapeutics share’s latest price of $3.97 as on November 2, 2026 at 8:46 am IST, you will get 2.5189 shares of Aclaris Therapeutics. Learn more about
fractional shares .
What are the returns that Aclaris Therapeutics has given to Indian investors in the last 5 years?
Aclaris Therapeutics stock has given -75.91% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?